Nicolaas A. Verwey

Amyloid-β(1–42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease

Cees Mulder, Nicolaas A. Verwey, Wiesje M. van der Flier et al. · Clinical Chemistry · 2009 · 344 citations · Full text

Medicine, Neurology, Neuroscience +17

Assessment of cognition in Parkinson’s disease

Johan Marinus, Martine Visser, Nicolaas A. Verwey et al. · Neurology · 2003 · 344 citations

Medicine, Neurology, Neuroscience +13

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

Niki S.M. Schoonenboom, Fransje E. Reesink, Nicolaas A. Verwey et al. · Neurology · 2011 · 305 citations · Full text

Medicine, Neurology, Neuroscience +17

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

Nicolaas A. Verwey, Wiesje M. van der Flier, Kaj Blennow et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 2009 · 169 citations

Life Sciences, Neurology, Neuroscience +17

Relationship of Cerebrospinal Fluid Markers to¹¹C-PiB and¹⁸F-FDDNP Binding

Nelleke Tolboom, Wiesje M. van der Flier, Maqsood Yaqub et al. · Journal of Nuclear Medicine · 2009 · 158 citations · Full text

Life Sciences, Neurobiology, Neurology +17